Actively Recruiting
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
Led by Michael Moront · Updated on 2026-02-20
300
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The safety and efficacy of the Mosaic bioprosthetic heart valves for cardiac valve replacement in the aortic position has been well documented throughout the literature. However, few studies assessing structural valve deficiency, patient outcomes and overall product performance in patients under the age of 65 exists for the Mosaic mitral valve bioprosthetic. This study aims to assess valve efficacy, stability, and post operative outcomes in patients who have received the Mosaic mitral valve prothesis at ProMedica Toledo Hospital and were under the age of 65.
CONDITIONS
Official Title
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Received the Mosaic Mitral Valve Bioprosthetic at ProMedica Toledo Hospital
- Under the age of 65
You will not qualify if you...
- Over the age of 65
- Under the age of 18
- Surgery performed at institutions outside of ProMedica Toledo Hospital
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ProMedica Toledo Hospital
Toledo, Ohio, United States, 43606
Actively Recruiting
Research Team
D
Dawn Muskiewicz, MS
CONTACT
L
Leah Stevenson, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here